Journey Strategic Wealth’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,087
Closed -$295K 876
2025
Q4
$295K Buy
+6,087
New +$302K 0.01% 514
2025
Q3
Sell
-8,486
Closed -$410K 767
2025
Q2
$410K Buy
+8,486
New +$434K 0.01% 340

Other funds holding SNY

Journey Strategic Wealth's SNY Position: Q1 2026 in Review

Journey Strategic Wealth sold out of Sanofi (SNY) in Q1 2026, closing a stake of 6,087 shares — an estimated $295K sold.

Journey Strategic Wealth first reported a position in SNY in Q2 2025 and held it in 2 quarters. The position peaked at $410K in Q2 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Journey Strategic Wealth reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Journey Strategic Wealth sold 6,087 Sanofi shares in Q1 2026, an estimated $295K.
  • Journey Strategic Wealth first reported a position in Sanofi in Q2 2025 and held it in 2 quarters.
  • Journey Strategic Wealth's Sanofi position peaked at $410K in Q2 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.